VIVO BIO TECH LTD. Share Price

₹ 13.90

+₹0.18 (1.31%)

Last updated 02 Nov, 2026, 15:28 IST

NSE: VIVOBIOT

VIVO BIO TECH LTD. Share Price Today

As of 3 Nov 2026, VIVO BIO TECH LTD. share price is ₹13.90. The stock opened at ₹13.99, compared to its previous close of ₹13.72. During today's trading session, VIVO BIO TECH LTD. share price moved in the range of ₹13.72 to ₹14.49, with an average price of ₹14.11 for the day. Looking at its last 52-week, the stock has touched a low of ₹12.00 and a high of ₹20.94. On the performance front, VIVO BIO TECH LTD. share price has declined by 24.17% over the last six months and is down 24.17% on a year-on-year basis.

₹13.72

1.31% up today

₹14.49

1D LOW

1D HIGH

VIVO BIO TECH LTD. Stock Insights

Latest Earning

Op Profit TrendUp by 36.00% QoQ

Latest Earning

Net Profit TrendUp by 103.68% QoQ

Latest Earning

Revenue TrendUp by 0.77% QoQ

Stock Performance

UnderperformingUnderperforming Nifty by 19.76 % in last 1 yr

Shareholding Pattern

PromoterPromoter decreased stake by 26.49%

VIVO BIO TECH LTD. Stock Insights

Latest Earning

Op Profit TrendUp by 36.00% QoQ

Latest Earning

Net Profit TrendUp by 103.68% QoQ

Latest Earning

Revenue TrendUp by 0.77% QoQ

Stock Performance

UnderperformingUnderperforming Nifty by 19.76 % in last 1 yr

Shareholding Pattern

PromoterPromoter decreased stake by 26.49%

VIVO BIO TECH LTD. stock performance
Open	₹13.99
High	₹14.49
Low	₹13.72
Prev. close	₹13.72

VIVO BIO TECH LTD. trading activity
Volume	9,648
Average traded price	₹14.25
Last traded time	03:28:34 02 Nov
Last traded quantity	3

₹10.98₹16.46

Circuit Low

Circuit High

₹12.00₹20.94

52-Week Low

52-Week High

Circuit

₹10.98

₹16.46

52-week

₹12.00

₹20.94

Mkt Cap Cr

30.69

P/E

-10.72

P/B

0.34

ROA

-1.6%

ROE

-1.83%

ROCE

6.64%

Quick Ratio

0.67

EV/EBITDA

4.64

Mkt Cap Cr

30.69

P/E

-10.72

P/B

0.34

ROA

-1.6%

ROE

-1.83%

ROCE

6.64%

Quick Ratio

0.67

EV/EBITDA

4.64

Based on fundamentals, this stock's

Performance

Very Poor

Vivo Bio Tech has not beaten FD return of 7%

Valuation

Overvalued

Vivo Bio Tech appears overvalued compared to its peers

Earnings

Good

Vivo Bio Tech revenue, operating profit and net profit are growing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,26,661.74	38.83	4.78	9.61%	13.79%	18.65%	2.31	22.27
Divis Laboratories	2,57,902.73	88.17	15.39	14.6%	15.32%	19.56%	3.5	58.97
Torrent Pharmaceuticals	1,76,306.21	84.0	9.6	4.7%	11.42%	11.37%	0.75	33.6
Laurus Labs	1,29,242.68	97.0	21.33	11.58%	22.11%	20.91%	0.68	54.77
Zydus Lifesciences	1,24,089.48	27.02	4.58	8.57%	18.59%	17.35%	0.91	16.42
Dr. Reddy's Laboratories	1,12,698.53	40.84	2.9	4.79%	7.21%	8.58%	1.35	19.05
Cipla	1,11,486.14	39.06	3.15	6.6%	8.18%	10.8%	2.5	21.03
Mankind Pharma	1,02,796.60	45.42	5.85	7.82%	12.76%	14.68%	0.74	25.01
Aurobindo Pharma	96,536.90	26.02	2.55	6.34%	9.25%	11.76%	1.15	12.38
Lupin	91,870.16	16.55	4.09	14.47%	23.76%	24.88%	1.42	9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

VIVO BIO TECH LTD. Company Background

ISIN

INE380K01017

Sector Market Cap

₹ 30.69 Cr

Vivo Bio Tech Limited is an India-based company, which is a comprehensive preclinical clinical research organization (CRO) serving pharmaceutical and biotech firms. It operates in the biotechnology segment. It provides integrated discovery, development & regulatory services to pharmaceutical, agrochemical, industrial chemical, vaccines, nutraceutical & medical device companies. The Company's services include in-Vivo and in-Vitro toxicity studies, pharmacological investigations, pharmacokinetic, toxicokinetic studies, genotoxicity screening and analytical services. It screens and assesses molecules for diverse pharmacological properties. In oncology, it designs syngeneic/xenograft models for anti-cancer agent evaluation. It customizes in-Vivo DMPK studies for rodent and non-rodent models to profile drug candidates. It provides both regulatory and non-regulatory IND-enabling preclinical development services.

VIVO BIO TECH LTD. Financial Highlights

Revenue: VIVO BIO TECH LTD. reported revenue of ₹53.77 crore in FY26 vs ₹51.47 crore in FY25. It showed an increase of 4.47% on a yearly basis.
Operating Profit: VIVO BIO TECH LTD. reported an operating profit of ₹4.81 crore in FY26 vs ₹8.79 crore in FY25. It showed a decrease of 45.28% on a year-on-year basis.
Net Profit: VIVO BIO TECH LTD. reported a net loss of ₹1.71 crore in FY26 vs ₹7.28 crore in FY25. It showed a decrease of 123.49% on a yearly basis.

VIVO BIO TECH LTD. Quarterly Result Highlights

VIVO BIO TECH LTD. reported revenue of ₹14.34 crore in Jun 2026, compared with ₹14.23 crore in Mar 2026, representing an increase of 0.77% on a quarter-on-quarter (QoQ) basis.
VIVO BIO TECH LTD. reported an operating profit of ₹0.34 crore in Jun 2026, compared with ₹0.25 crore in Mar 2026, representing an increase of 36.00% on a quarter-on-quarter (QoQ) basis.
VIVO BIO TECH LTD. reported a profit of ₹0.19 crore in Jun 2026, compared with ₹5.16 crore in Mar 2026, reflecting an increase of 103.68% on a QoQ basis.
The earnings per share (EPS) of VIVO BIO TECH LTD. stood at ₹0.82 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

22.51%

FII

0.00%

Other DII

0.00%

Retail and other

77.49%

Mutual funds

0.00%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	0.00%
Mar 2026	0.00%
Jun 2026	0.00%
Sep 2026	0.00%

VIVO BIO TECH LTD. Investment Returns

1 day

+4.30%

1 week

+11.02%

1 month

-16.46%

1 year

-24.17%

3 years

-24.17%

5 years

-24.17%

VIVO BIO TECH LTD. Share Price History

VIVO BIO TECH LTD. share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
02 Nov 26	₹13.99 / ₹13.90	+1.31%
30 Oct 26	₹14.29 / ₹13.72	-1.86%
29 Oct 26	₹13.58 / ₹13.98	+0.79%
28 Oct 26	₹14.18 / ₹13.87	-2.19%
27 Oct 26	₹12.58 / ₹14.18	+10.01%
26 Oct 26	₹12.66 / ₹12.89	-0.31%
23 Oct 26	₹14.70 / ₹12.93	-12.04%
22 Oct 26	₹13.80 / ₹14.70	+5.68%
21 Oct 26	₹13.70 / ₹13.91	+2.05%
19 Oct 26	₹13.66 / ₹13.63	-5.15%

VIVO BIO TECH LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹53.33	₹46.67	₹45.45	₹52.23
Other Income	₹0.44	₹4.80	₹0.04	₹0.04
Total Revenue	₹53.78	₹51.48	₹45.49	₹52.27
Total Expenses	₹48.36	₹42.68	₹41.43	₹47.65
Profit Before Tax	₹4.81	₹8.79	₹4.06	₹4.62
Tax	₹6.52	₹1.51	₹1.53	₹1.97
Profit After Tax	-₹1.71	₹7.28	₹2.53	₹2.65
EPS - Basic	-₹0.82	₹4.76	₹1.70	₹1.78
EPS - Diluted	-₹0.82	₹4.76	₹1.51	₹1.78

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹4.81	₹8.79	₹4.06	₹4.62
Income before WC changes	₹21.29	₹20.70	₹21.13	₹21.54
Change in Assets	₹13.68	₹5.23	-₹15.43	-₹6.15
Change in Liabilities	₹2.57	-₹10.56	₹12.88	₹2.79
Change in WC	₹16.24	-₹5.32	-₹2.55	-₹3.37
Cash flow from Operations	₹34.93	₹11.83	₹15.52	₹14.83
Cash flow from Investing	-₹59.35	-₹15.84	-₹7.95	-₹4.00
Cash flow from Financing	₹24.57	₹3.90	-₹7.56	-₹11.18
Total Cash Flow	₹0.15	-₹0.11	₹0.01	-₹0.34
Cash (Start of the year)	₹1.28	₹1.39	₹1.37	₹1.71
Cash (End of the year)	₹1.44	₹1.28	₹1.39	₹1.37

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹150.02	₹101.29	₹89.90	₹91.24
Current Assets	₹28.42	₹41.94	₹47.23	₹31.79
Total Assets	₹178.43	₹143.23	₹137.13	₹123.03
Current Liabilities	₹30.23	₹27.84	₹37.91	₹24.97
Net Current Asset	-₹1.82	₹14.10	₹9.32	₹6.82
Non-Current Liabilities	₹55.04	₹37.49	₹44.82	₹46.19
Equity Capital	₹93.16	₹77.90	₹54.40	₹51.87
Total Equity & Liabilities	₹178.43	₹143.23	₹137.13	₹123.03

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹52.57	₹46.67	₹44.88	₹51.62
Other Income	₹0.44	₹4.80	₹0.04	₹0.04
Total Revenue	₹53.01	₹51.48	₹44.92	₹51.66
Total Expenses	₹47.82	₹42.40	₹40.86	₹47.05
Profit Before Tax	₹4.58	₹9.08	₹4.05	₹4.61
Tax	₹6.52	₹1.51	₹1.53	₹1.97
Profit After Tax	-₹1.94	₹7.57	₹2.52	₹2.63
EPS - Basic	-₹0.93	₹4.95	₹1.69	₹1.77
EPS - Diluted	-₹0.93	₹4.95	₹1.51	₹1.77

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹4.58	₹9.08	₹4.05	₹4.61
Income before WC changes	₹21.06	₹20.99	₹21.12	₹21.52
Change in Assets	₹15.24	₹4.85	-₹15.01	-₹6.25
Change in Liabilities	₹2.41	-₹9.89	₹12.78	₹2.79
Change in WC	₹17.64	-₹5.04	-₹2.24	-₹3.46
Cash flow from Operations	₹36.11	₹11.83	₹15.83	₹14.73
Cash flow from Investing	-₹59.35	-₹15.84	-₹7.95	-₹4.00
Cash flow from Financing	₹23.34	₹3.90	-₹7.56	-₹11.20
Total Cash Flow	₹0.09	-₹0.11	₹0.32	-₹0.47
Cash (Start of the year)	₹1.21	₹1.32	₹0.99	₹1.47
Cash (End of the year)	₹1.30	₹1.21	₹1.32	₹0.99

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹146.70	₹97.97	₹86.58	₹87.92
Current Assets	₹28.17	₹43.31	₹48.22	₹32.88
Total Assets	₹174.86	₹141.29	₹134.80	₹120.81
Current Liabilities	₹30.07	₹27.84	₹37.81	₹24.97
Net Current Asset	-₹1.90	₹15.48	₹10.41	₹7.92
Non-Current Liabilities	₹51.58	₹35.26	₹42.59	₹43.96
Equity Capital	₹93.22	₹78.19	₹54.40	₹51.87
Total Equity & Liabilities	₹174.86	₹141.29	₹134.80	₹120.81